Carrie Madormo, RN, MPH, is a health writer. She has over a decade of experience as a registered nurse, practicing in a variety of fields, such as pediatrics, oncology, chronic pain, and public health ...
Between 2020 and 2024, the number of unique sites in the United States where phase I clinical trials for non-small cell lung ...
Sapience Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery and development of peptide ...
Faculty in this hub lead the design, coordination, and analysis of clinical trials for cancer treatment, survivorship, vaccine efficacy, infectious disease prevention and treatment, and cancer ...
Dr. Adil Shamoo does an admirable job of debunking the legitimacy of using "equipoise" to justify the conduct of phase 1 clinical trials and, by extension, phase 2 and 3 clinical trials. [1] To the ...
Overall, TherVacB was found to be safe, well-tolerated, and highly immunogenic among the healthy study participants.
The recent federal action directing the FDA to accelerate the review of psychedelic therapies marks a major shift in the ...
DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been rated as one of the top-performing contract research ...
Balstilimab is a novel, fully human monoclonal immunoglobulin G4 (IgG4) designed to block PD-1 (programmed cell death protein 1) from interacting with its ligands PD-L1 and PD-L2. It has been ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results